Tumor lysate-loaded biodegradable microparticles as cancer vaccines. - Wikidata - wikimedia - TriplyDB

Tumor lysate-loaded biodegradable microparticles as cancer vaccines.

Tumor lysate-loaded biodegradable microparticles as cancer vaccines.

http://www.wikidata.org/entity/Q37670779

about

In Vivo Synthesis of Cyclic-di-GMP Using a Recombinant Adenovirus Preferentially Improves Adaptive Immune Responses against Extracellular Antigens.A therapeutic microparticle-based tumor lysate vaccine reduces spontaneous metastases in murine breast cancer.Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.Recent progress in GM-CSF-based cancer immunotherapy.A simple, clinically relevant therapeutic vaccine shows long-term protection in an aggressive, delayed-treatment B lymphoma model.Therapeutic cancer vaccines.Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer.

P2860

Q33924419-A59EEFC1-08FE-4F60-9433-A25898E6D7F2 Q35318315-2012E245-F6E3-4B69-9B9E-D01CE2A8F6AA Q36396099-1FCF13E5-C696-4EC2-B047-65CEE3021957 Q39183386-B289CCEA-BC92-4FCC-850C-F08269E7AF80 Q47357871-77540309-8476-4426-A65E-1C09B3146D87 Q50988785-20FCE6CB-0100-4973-8DD3-2C4CCE93DB2B Q52746279-70B05876-D670-484B-96AA-002005DC9871

P2860

Tumor lysate-loaded biodegradable microparticles as cancer vaccines.

http://www.wikidata.org/entity/Q37670779

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tumor lysate-loaded biodegradable microparticles as cancer vaccines.

@en

Tumor lysate-loaded biodegradable microparticles as cancer vaccines.

@nl

type

label

Tumor lysate-loaded biodegradable microparticles as cancer vaccines.

@en

Tumor lysate-loaded biodegradable microparticles as cancer vaccines.

@nl

prefLabel

Tumor lysate-loaded biodegradable microparticles as cancer vaccines.

@en

Tumor lysate-loaded biodegradable microparticles as cancer vaccines.

@nl

P1433

Q37670779-72EF203D-B726-4806-AD9F-2C31E153642C

P1476

Q37670779-D0AF7603-6AD9-4663-8E50-B099E7D8673D

P2093

Q37670779-2C16F5B0-D977-437F-AF0D-2B2597880310

Q37670779-2C9073D9-BE49-40EF-965E-7AB5A4AC4C49

Q37670779-D2D35869-12F3-4DB4-B461-94AA027E4DFC

Q37670779-D3F02EBE-2BE7-45A7-8FF0-53F1DA81D4BA

P2860

Q37670779-03FD940F-8C25-44AB-9672-6BE6999D64A7

Q37670779-06647F22-52FA-43A9-96CC-C5494B59AC02

Q37670779-0A024760-1BCD-4D33-837A-0B5427224E25

Q37670779-0F32DE43-F4D6-4278-87C8-E78AEFCE5574

Q37670779-107C11A3-E09A-4517-BD39-D8EB42F79EA6

Q37670779-130E3E8A-ADD6-4812-855D-147214E96A60

Q37670779-15D38F33-C8B5-410A-9DB9-9F16C91671C9

Q37670779-165DCBAF-5B31-452A-947B-9B01AD981517

Q37670779-1CD999CB-C211-41F9-822E-6C95D6AC6B2A

Q37670779-22C0B774-E3E0-48D7-B929-C2A17170ABC9

P304

Q37670779-89444BE0-83AD-42EF-8BE5-E5FA6AA692C1

P31

Q37670779-A4653D63-44DB-4233-8FEB-B2AC59364D25

P356

Q37670779-759A458C-051A-4AD6-AEB4-5567BDC99941

P433

Q37670779-D98A6D3E-5831-4970-AC11-B9C2ACBD5BCC

P478

Q37670779-17D7DFD4-F220-48A3-9743-FE461479E744

P50

Q37670779-232FDF1D-C752-472C-988D-CCF567D3A948

Q37670779-250F3964-F1E4-4590-96B4-5DF88BD88503

P577

Q37670779-63B29B6D-0472-4881-A58A-FE71FD9220C1

P5875

Q37670779-7260850A-1342-47F1-B690-0072C58BDEAB

P698

Q37670779-0A728239-244B-4FF2-9F02-8C0D7A1F5575

P921

Q37670779-148B00A7-9B1B-404C-85C7-7F192429B539

P932

Q37670779-A76C24E5-8D47-4CE0-B6CC-816DA66D0490

P356

14760584.2014.851606

P1433

Expert Review of Vaccines

P1476

Tumor lysate-loaded biodegradable microparticles as cancer vaccines.

@en

P2093

Brett P Gross

http://www.w3.org/2001/XMLSchema#string

Lyse A Norian

http://www.w3.org/2001/XMLSchema#string

Sean M Geary

http://www.w3.org/2001/XMLSchema#string

Vijaya B Joshi

http://www.w3.org/2001/XMLSchema#string

P2860

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Heat shock proteins: stimulators of innate and acquired immunity

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

Myeloid-derived suppressor cells as regulators of the immune system

Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?

Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.

Next-generation cancer vaccine approaches: integrating lessons learned from current successes with promising biotechnologic advances

Toll-like receptor agonists: are they good adjuvants?

PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity.

P304

9-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14760584.2014.851606

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Amaraporn Wongrakpanich

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258500173

http://www.w3.org/2001/XMLSchema#string

P698

24219096

http://www.w3.org/2001/XMLSchema#string

P921

P932

3968791

http://www.w3.org/2001/XMLSchema#string